Please provide your email address to receive an email when new articles are posted on . Three of four patients with neuroblastoma had stable disease through four or more treatment cycles. Phase 2 is ...

Developing a new molecular entity is a lengthy, expensive and high-risk endeavour. Reformulating drugs that have been proven to be safe and effective into fixed-dose combination (FDC) products ...